博拓生物：第四届董事会第四次会议决议公告

Group 1 - The core point of the article is that Botao Bio has announced the approval of several key proposals during its fourth board meeting, including anticipated related party transactions for the year 2026 [2] - The company plans to revise and add certain internal regulations as part of its governance improvements [2] - A proposal to convene the first extraordinary shareholders' meeting of 2026 has also been put forward [2]